Consistently, levels of pathological tau (soluble and insoluble pS396/404-tau, and insoluble total tau) were significantly higher in AD than controls in both brain regions (all P<0.0001, Table S9), while the levels of soluble total tau did not differ noticeably between these two groups. This evidence concerns the gene MAPT and Alzheimer disease.